gene editing Archives - Page 5 of 5 -

CRISPR Therapeutics, the Swiss genome-editing company, has filed for a $90 million initial public offering. The company is

CRISPR Therapeutics plans Nasdaq launch

https://pharmaphorum.com/news/crispr-therapeutics-plans-nasdaq-launch/

Company launched following $55 million series A funding round.

Fulcrum Therapeutics promises new drugs for rare disorders

https://pharmaphorum.com/news/fulcrum-therapeutics-promises-new-drugs-rare-disorders/

Genetic engineering specialist Caribou Biosciences has secured $30 million in a series B funding round. New investors Anterra

Caribou gains $30m funding for CRISPR-Cas platform

https://pharmaphorum.com/news/caribou-biosciences-nabs-30m-funding-for-crispr-cas-platform/

gene editing